Should the non‐canonical pathway of nitric oxide generation be targeted in hypertensive pregnancies?
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.16276 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Elizabeth C Cottrell. Beteiligte Einrichtung: Maternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and…. Hauptthemen laut MEDLINE: Nitric Oxide, Hypertension, Pregnancy-Induced, Nitrates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Tommy's Baby Charity.
Abstract (Originalsprache)
Hypertension in pregnancy is prevalent, affecting around 10% of pregnancies worldwide, and significantly increases the risk of adverse outcomes for both mothers and their babies. Current treatment strategies for pregnant women with hypertension are limited, and new approaches for the management of hypertension in pregnancy are urgently needed. Substantial evidence from non‐pregnant subjects has demonstrated the potential for dietary nitrate supplementation to increase nitric oxide (NO) bioavailability and lower blood pressure, following bioactivation via the non‐canonical NO pathway. Emerging data suggest this approach may also be of benefit in pregnant women, although studies are limited. This review aims to summarise the current evidence from preclinical and clinical studies of nitrate supplementation in pregnancy, drawing on data from non‐pregnant populations where appropriate and highlighting key gaps in knowledge that remain to be addressed in future trials. LINKED ARTICLES This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Maternal and Fetal Health Research Centre, Division of Developmental Biology & Medicine, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
ORCID-Profile: Elizabeth C Cottrell
Förderung
- British Heart Foundation
- Tommy's Baby Charity
Zitieren
APA
Cottrell, E. C. (2026). Should the non‐canonical pathway of nitric oxide generation be targeted in hypertensive pregnancies?. British Journal of Pharmacology. https://doi.org/10.1111/bph.16276
Vancouver
Cottrell EC. Should the non‐canonical pathway of nitric oxide generation be targeted in hypertensive pregnancies?. British Journal of Pharmacology. 2026. doi:10.1111/bph.16276
BibTeX
@article{Cottrell2026,
author = {Cottrell, Elizabeth C},
title = {Should the non‐canonical pathway of nitric oxide generation be targeted in hypertensive pregnancies?},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.16276}
}
EUVIMED